Boosting the Potential of Chemotherapy in Advanced Breast Cancer Lung Metastasis via Micro‐Combinatorial Hydrogel Particles

Breast cancer cell colonization of the lungs is associated with a dismal prognosis as the distributed nature of the disease and poor permeability of the metastatic foci challenge the therapeutic efficacy of small molecules, antibodies, and nanomedicines. Taking advantage of the unique physiology of the pulmonary circulation, here, micro‐combinatorial hydrogel particles (µCGP) are realized via soft lithographic techniques to enhance the specific delivery of a cocktail of cytotoxic nanoparticles to metastatic foci. By cross‐linking short poly(ethylene glycol) (PEG) chains with erodible linkers within a shape‐defining template, a deformable and biodegradable polymeric skeleton is realized and loaded with a variety of therapeutic and imaging agents, including docetaxel‐nanoparticles. In a model of advanced breast cancer lung metastasis, µCGP amplified the colocalization of docetaxel‐nanoparticles with pulmonary metastatic foci, prolonged the retention of chemotoxic molecules at the diseased site, suppressed lesion growth, and boosted survival beyond 20 weeks post nodule engraftment. The flexible design and modular architecture of µCGP would allow the efficient deployment of complex combination therapies in other vascular districts too, possibly addressing metastatic diseases of different origins.

[1]  M. Esteller,et al.  Accelerated biological aging in COVID-19 patients , 2022, Nature Communications.

[2]  P. Decuzzi,et al.  Boosting the Therapeutic Efficacy of Discoidal Nanoconstructs against Glioblastoma with Rationally Designed PEG-Docetaxel Conjugates. , 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[3]  H. Nia,et al.  Solid stress impairs lymphocyte infiltration into lymph-node metastases , 2021, Nature Biomedical Engineering.

[4]  P. Decuzzi,et al.  Vascular-confined multi-passage discoidal nanoconstructs for the low-dose docetaxel inhibition of triple-negative breast cancer growth , 2021, Nano Research.

[5]  P. Decuzzi,et al.  Harnessing Endogenous Stimuli for Responsive Materials in Theranostics , 2021, ACS nano.

[6]  S. Mitragotri,et al.  Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases , 2020, Nature Biomedical Engineering.

[7]  P. Decuzzi,et al.  Optimizing the Pharmacological Properties of Discoidal Polymeric Nanoconstructs Against Triple-Negative Breast Cancer Cells , 2020, Frontiers in Bioengineering and Biotechnology.

[8]  S. Mitragotri,et al.  Erythrocyte leveraged chemotherapy (ELeCt): Nanoparticle assembly on erythrocyte surface to combat lung metastasis , 2019, Science Advances.

[9]  Fabian Kiessling,et al.  Smart cancer nanomedicine , 2019, Nature Nanotechnology.

[10]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[11]  Samir Mitragotri,et al.  Nanoparticles in the clinic: An update , 2019, Bioengineering & translational medicine.

[12]  G. Hortobagyi,et al.  Current Landscape of Immunotherapy in Breast Cancer: A Review. , 2019, JAMA oncology.

[13]  M. King,et al.  Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection , 2019, Science Advances.

[14]  K. Toh,et al.  Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. , 2019, ACS nano.

[15]  D. Bertsimas,et al.  Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis , 2019, Breast Cancer Research and Treatment.

[16]  M. Moses,et al.  Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis , 2019, Science Advances.

[17]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[18]  P. Decuzzi,et al.  Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots. , 2018, ACS nano.

[19]  J. Lahann,et al.  Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude , 2018, Nature Communications.

[20]  Fabian Kiessling,et al.  Tumor targeting via EPR: Strategies to enhance patient responses. , 2018, Advanced drug delivery reviews.

[21]  P. Decuzzi,et al.  Modulating Phagocytic Cell Sequestration by Tailoring Nanoconstruct Softness. , 2018, ACS nano.

[22]  A. Rauth,et al.  Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice , 2017, Acta Pharmacologica Sinica.

[23]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[24]  Baran D. Sumer,et al.  A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery , 2016, Nature Biomedical Engineering.

[25]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[26]  P. Decuzzi,et al.  Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[27]  Haijun Yu,et al.  Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer. , 2016, ACS nano.

[28]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[29]  Mauro Ferrari,et al.  An injectable nanoparticle generator enhances delivery of cancer therapeutics , 2016, Nature Biotechnology.

[30]  P. Decuzzi,et al.  Tuning core hydrophobicity of spherical polymeric nanoconstructs for docetaxel delivery , 2016 .

[31]  D. Zhong,et al.  A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer , 2016, Theranostics.

[32]  Jaehong Key,et al.  Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors. , 2015, ACS nano.

[33]  Yinan Zhong,et al.  Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. , 2014, Biomacromolecules.

[34]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[35]  G. Pillai,et al.  Nanomedicines for Cancer Therapy : An Update of FDA Approved and Those under Various Stages of Development , 2014 .

[36]  Samir Mitragotri,et al.  Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. , 2013, ACS nano.

[37]  Jaehong Key,et al.  Engineering discoidal polymeric nanoconstructs with enhanced magneto-optical properties for tumor imaging. , 2013, Biomaterials.

[38]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[39]  Xiaoyuan Chen,et al.  Integrin Targeted Delivery of Radiotherapeutics , 2011, Theranostics.

[40]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[41]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[42]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[43]  B. Felding-Habermann,et al.  Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain , 2009, Proceedings of the National Academy of Sciences.

[44]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  M. Penn,et al.  Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets. , 2008, Biomaterials.

[46]  Andreas Greiner,et al.  Electrospinning: a fascinating method for the preparation of ultrathin fibers. , 2007, Angewandte Chemie.

[47]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  L. Rivory,et al.  Clinical Pharmacokinetics of Docetaxel , 1999, Clinical pharmacokinetics.

[49]  Elazer R. Edelman,et al.  Adv. Drug Delivery Rev. , 1997 .

[50]  Clive G. Wilson,et al.  Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape , 1982 .